Health Care/Hospital

Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition

* Data spans five abstracts including two oral presentations with important findings for patients living with blastic plasmacytoid dendritic cell neoplasm (BPDCN) * BPDCN is a highly aggressive, orphan hematologic malignancy that primarily affects skin, bone marrow, and blood FLORENCE, Italy...

2025-11-24 23:34 1117

Alzheimer's Association Statement on Oral Semaglutide Phase 3 Topline Data Release

- Results Underscore Need for Continued Research and Diverse Treatment Pipeline CHICAGO, Nov. 24, 2025 /PRNewswire/ -- The Alzheimer's Association is disappointed that the evoke and evoke+ clinical trials did not demonstrate a statistically significant reduction in Alzheimer's disease progression...

2025-11-24 23:19 900

The Volpi Rosse Menarini: The 'Fantastic Ten' are ready for the 2025 - 2026 Season

Italian wheelchair basketball team, sponsored by Menarini, was presented to the press and public inItaly. The challenges they will be facing in the Italian Serie A and Eurocup 3 are already on the horizon FLORENCE, Italy, Nov. 24, 2025 /PRNewswire/ -- Ten international talents, differing in both...

2025-11-24 22:40 823

ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics

* Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology * Pursues a "once-and-done" treatment paradigm for diseases with high unmet medical needs SEOUL, South Korea, Nov. 24, 2025 /PRNewswire/ -- ToolGen Inc. (K...

2025-11-24 22:00 1067

Pinnacle Food Announces New Strategic Initiative to Expand its Smart Agriculture Innovation Platform

VANCOUVER, BC, Nov. 24, 2025 /PRNewswire/ -- Pinnacle Food Group Limited (NASDAQ:PFAI) announced a strategic initiative to establish a bioengineering and testing laboratory. The Company is exploring applied bioengineering initiatives to further expand its smart agriculture innovation platform int...

2025-11-24 21:00 816

Kelun-Biotech Announces Phase III Trial of Sac-TMT in Combination with KEYTRUDA® (pembrolizumab) as First-Line Treatment for PD-L1-Positive NSCLC Met Primary Endpoint

CHENGDU, China, Nov. 24, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded that the Phase III clinical study (OptiTROP-Lung05) of the company's TROP2 ADC sacituzumab tiru...

2025-11-24 20:00 1066

Triple the Probiotics, Triple the Relief: Life-Space Launches Triple Strength Probiotics in Southeast Asia

Engineered by Australia's leading probiotics expert, this high CFU probiotic delivers the ultimate gut defense, helping to reduce gut transit time by up to 18 hours. SINGAPORE, Nov. 24, 2025 /PRNewswire/ -- Life-Space, Australia's No.1 probiotic brand, proudly unveilsTriple Strength Probiotics, ...

2025-11-24 18:29 1109

HoneyNaps Accelerates Clinical Trial Pipelines with FDA-Cleared AI "SOMNUM"

* Enhancing Clinical Efficiency with AI Sleep Analysis: Cutting Both Cost and Time * Joint Clinical Studies with CROs: SOMNUM™ AI Sleep Scoring Drives Higher Efficiency * FDA-cleared AI solution shortens clinical trial timelines while ensuring data reliability * Expanded global partnershi...

2025-11-24 17:24 639

Beyfortus® (nirsevimab) now available in Malaysia to protect all infants against RSV disease

* Beyfortus® (nirsevimab) is an available option designed to protect all infants – whether born full-term or pre-term, healthy or with underlying conditions – against respiratory syncytial virus (RSV), with proven high and sustained efficacy, a favourable safety profile, and real-world public h...

2025-11-24 16:55 1484

/C O R R E C T I O N -- The Genovation Foundation/

In the news release, Dr James Liang Launches HK$500 Million "Genovation Foundation" to Address Low Fertility, issued20-Nov-2025 by The Genovation Foundation over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows: Dr James Liang Launch...

2025-11-24 16:31 1243

Pin Therapeutics Initiates First-Patient Dosing of CK1α Degrader PIN-5018 in Phase 1 Trial

Preclinical Results Demonstrate Complete Response and Tumor Regression in ACC PDX Models SEOUL, South Korea, Nov. 24, 2025 /PRNewswire/ -- Pin Therapeutics, a clinical-stage biotechnology company specializing in targeted protein degradation, announced onNovember 20 that it has administered the f...

2025-11-24 15:11 793

Cigna Healthcare International Health Study Shows Physical Health Remains a Top Priority Despite Rising Stress in Hong Kong

* More than half of Hongkongers (54%) rank physical health as their top well-being priority, compared to around one in three globally (35%) * Weight management emerges as a key health focus, with 43% of Hongkongers prioritizing weight maintenance, well above the global average of 36%. Only 36%...

2025-11-24 12:26 1032

Chula Veterinarians Perform Thailand's First Pacemaker Implant in a Cat

BANGKOK, Nov. 24, 2025 /PRNewswire/ -- In a groundbreaking medical milestone, veterinarians fromChulalongkorn University 's Faculty of Veterinary Science have successfully performedThailand's first pacemaker implantation in a cat

2025-11-24 12:00 864

Harbour BioMed Advances Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Biotherapeutics in Oncology

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Nov. 23, 2025 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics for immunology and oncology, today announced an u...

2025-11-24 08:01 1164

GenEditBio and ToolGen Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics

* Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology * Pursues a "once-and-done" treatment paradigm for diseases with high unmet medical needs SEOUL, South Korea and HONG KONG, Nov. 24, 2025 /PRNewswire/ -- G...

2025-11-24 08:00 1212

Exploring the Next Era of CGT and Unlocking Limitless Possibilities: The GenScript Biotech Global Forum London 2025 Wraps Up

PISCATAWAY, N.J., Nov. 22, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the GenScript Biotech Global Forum London 2025 in the UK. This marks the Forum's second edition inEurope and the eighth consecutive G...

2025-11-22 20:28 1744

Exploring the Next Era of CGT and Unlocking Limitless Possibilities: The GenScript Biotech Global Forum London 2025 Wraps Up

PISCATAWAY, N.J., Nov. 21, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the GenScript Biotech Global Forum London 2025 in the UK. This marks the Forum's second edition inEurope and the eighth consecutive G...

2025-11-22 06:32 2129

Global Health Leaders Convene in Kuala Lumpur from 25-27 November for Malaysia International Healthcare Megatrends 2025

A Major Conference on Innovation, Digital Health and Sustainable Care Systems KUALA LUMPUR, Malaysia, Nov. 22, 2025 /PRNewswire/ -- Healthcare leaders, policymakers and innovators from around the world will convene inMalaysia next week for the Malaysia International Healthcare (MIH) Megatrends 20...

2025-11-22 02:05 3560

From Vietnam to Italy to the Middle East: Better by MTA Expands Platinum Network of Global Healthcare Excellence

PALM BEACH GARDENS, Fla., Nov. 22, 2025 /PRNewswire/ -- Better by MTA, the premier medical tourism platform dedicated to promoting transparency, access, and high quality in global healthcare, is proud to announce that three distinguished institutions have joined its network as Platinum Members:Vi...

2025-11-22 00:15 1936

Gerontech and Innovation Expo cum Summit 2025 20 to 23 November: Showcasing nearly 1000 innovative technology products and solutions to co-create smart ageing future

HONG KONG, Nov. 21, 2025 /PRNewswire/ -- The 9th Gerontech and Innovation Expo cum Summit (GIES), co-organised by the Hong Kong Special Administrative Region (HKSAR) Government and the Hong Kong Council of Social Service (HKCSS), and co-hosted by the Hong Kong Science and Technology Parks Corpora...

2025-11-21 22:58 2277
1 ... 6789101112 ... 860